Category: Uncategorised

Diabetic Retinopathy Industry Overview

The global diabetic retinopathy market size was valued at USD 6.6 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030. The rising prevalence of diabetes, growing geriatric population, and increasing prevalence of blindness due to diabetes are among the major factors anticipated to boost market growth over the forecast period. The market is further propelled by the increasing awareness about diabetes management and care and new product launches. Diabetes is a serious and growing problem globally, where the inefficiency of the pancreas to produce insulin results in an increase in blood glucose levels. Diabetic retinopathy is caused by damage to the blood vessels in the retina. This leads to blurred vision and vision loss in most cases.

Risk factors such as high blood sugar levels and poor monitoring of the constant fluctuating BG levels are said to fuel the cause of diabetic retinopathy. Early detection of diabetes in patients, treatment correction, constant self-monitoring by the patients using advanced tools, and adoption of a healthier lifestyle may reduce the damage to the retinal blood vessels, decreasing the prevalence of diabetic retinopathy among patients. Despite all the necessary measures adopted by the diabetic population, diabetic retinopathy can lead to permanent blindness, based on the disease stage and severity of the condition. According to the Department of Assistive and Rehabilitative Services (DARS), Texas, around 78.0% of cases of diabetic retinopathy were reported in 2013 which may eventually lead to loss of vision.

Gather more insights about the market drivers, restrains and growth of the Global Diabetic Retinopathy market

In addition, as per the Royal National Institute of Blind People (RNIB), diabetic retinopathy was among the leading causes of blindness in the U.K. in 2018. Rising patient awareness levels and increasing healthcare expenditure are also among the factors which are likely to propel market growth. Additionally, the WHO claims that the world’s aging population will more than double by 2050, as compared to that in 2020. Hence, it is important to maintain a healthy lifestyle, control obesity, and continuously monitor BG levels in the vulnerable population.

The COVID-19 pandemic impacted the market negatively. Closure of manufacturing units, dramatic economic decline, national lockdowns, shutting of logistic services, and reduced diagnostic activities due to the fear of virus spread were few among the many reasons for the dip in the market. Postponement of sales activities, reduction in R&D activities undertaken by leaders to launch advanced products, and most importantly, economic setbacks experienced by patients led to the dramatic decline in 2020. However, the market is said to bounce back by mid-2022.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Scar Treatment Market – The global scar treatment market was valued at USD 23.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.9% from 2023 to 2030.
• Cryoablation Devices Market – Cryoablation devices offer various benefits such as fewer side effects, easy recovery, cost-effective, etc. These benefits represent lucrative growth opportunities for the cryoablation market.

Diabetic Retinopathy Market Segmentation 

Grand View Research has segmented the global diabetic retinopathy market based on type, management, and region:

Diabetic Retinopathy Type Outlook (Revenue, USD Million, 2018 – 2030)

• Proliferative diabetic retinopathy
• Non-proliferative diabetic retinopathy

Diabetic Retinopathy Management Outlook (Revenue, USD Million, 2018 – 2030)

• Anti-VEGF
• Intraocular steroid injection
• Laser surgery
• Vitrectomy

Diabetic Retinopathy Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies profiled:

Some of the prominent players in the diabetic retinopathy market include:

• Bayer AG
• Allergan plc
• Novartis AG
• Oxurion NV
• Sirnaomics Inc.
• Genentech
• Alimera Sciences
• Ampio Pharmaceuticals
• BCN Peptides
• Kowa Company, Ltd.

Order a free sample PDF of the Diabetic Retinopathy Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Infection Control Industry Overview

The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The market is predominantly driven by growing number of surgical procedures that require high-intensity infection prevention. The high preference is presumed to be a consequence of positive clinical outcomes associated with usage of infection control. The covid-19 pandemic has positively impacted market growth as the demand for sterilization and disinfection in hospitals and clinics, pharmaceutical, and medical device companies has increased.

For instance, the manufacturing of sanitizer products witnessed rise of 60% during the pandemic in the U.S. alone. This shows the growth potential for infection control products in the coming years. An increase in outsourcing of sterilization services and the introduction of advanced sterilizing solutions are further contributing towards the growth of the market for infection control. The rising number of government initiatives to ensure a high degree infection prevention is presumed to be a significant growth driver.

Gather more insights about the market drivers, restrains and growth of the Global Infection Control market

Government organizations are increasingly involved in issuing guidelines in order to promote awareness pertaining to efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for the prevention and control of pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene, usage of personal protective equipment, to guidelines for disinfection, and sterilization.

According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs. The aforementioned statistics exemplify the high need for stringent prevention and control. Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, MRSA constitute majority of the overall hospital-acquired infections. Other major Hospital-acquired Infections (HAI) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstreams. HAI is believed to be one of the major concerns, that affects patient recovery, thereby, creating a major impact on mortality rates globally.

According to a practical guide published by the WHO on the prevention of HAI, the increase in hospitalization duration with surgical infections was found to be approximately 8 days. These prolonged stays are predicted to be a significant contributor to the overall costs, incurred during the hospitalization period, thus, raising the clinical urgency for adoption of infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers as a consequence of excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, laboratory equipment, creating a resource allocation imbalance.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Anastomosis Devices Market – The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030.

• Advanced Wound Care Market – The global advanced wound care market size was valued at USD 6.7 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030.

Infection Control Market Segmentation

 Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

 Infection Control Type Outlook (Revenue, USD Billion, 2017 – 2030)

• Equipment
  • Disinfectors
    • Washers
    • Flushes
    • Endoscope Reprocessors
  • Sterilization Equipment
    • Heat Sterilization Equipment
    • Low Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
  • Others
• Services
  • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
  • Infectious  Waste Disposal
• Consumables
  • Infectious  Waste Disposal
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

Infection Control End-use Outlook (Revenue, USD Billion, 2017 – 2030)

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Laboratories
• Others

 Infection Control Regional Outlook (Revenue, USD Billion, 2017 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• March 2017: 3M and Kimberly-Clark Health Care signed an alliance to co-develop and deliver surgical and infection prevention solutions utilizing their respective expertise.

Key Companies profiled:

Some of the prominent players in the infection control market include:

• 3M Company
• Belimed AG
• Halyard Health, Inc.
• Getinge Group
• Advanced Sterilization Products
• Matchana Group
• Sterigenics International
• MMM Group
• Cantel Medical Corporation
• STERIS Corporation

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Immunoassay Industry Overview

The global immunoassay market size was valued at USD 28.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030. The market growth can be attributed to the increase in chronic and infectious diseases, including the outbreak of COVID-19. In addition, the rise in the geriatric population, which is more prone to chronic and infectious diseases, will aid growth. An increase in the prevalence of chronic conditions, such as cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases, has led to the wide usage of immunoassay techniques in disease diagnostics. The incidence of cancer is increasing steadily, which is expected to drive the demand for effective diagnostic methods such as immunoassay. This technique is significant in the determination of oncogenesis and diagnosis of cancer, such as benign or malignant, and its different stages. It facilitates the use of monoclonal and polyclonal antibodies to detect specific antigens in tissues by determining the presence of tumor antigens.

Applications of immunoassay-based diagnostics are significantly increasing globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling the epidemic disease. Thus, increased patient awareness has led to high demand for immunoassays. For instance, the advocacy program by the International Society for Infectious Diseases focuses on collaborating with clinicians, public health practitioners, and researchers globally and supporting the exchange of scientific knowledge and application of public health practices and evidence-based medicine. In addition, in 2018, the World Hepatitis Alliance launched the “Find the Missing Millions” campaign to raise awareness regarding hepatitis and remove barriers in clinical diagnostic settings.

Gather more insights about the market drivers, restrains and growth of the Global Immunoassay market

Clinical interpretation of diagnostic tests is dependent on assay analyzers and the presence of a technical and skilled workforce. Results of assays are affected by the time taken for interpretation. Thus, technological advancements have led to an increase in the number of automated instruments and equipment used in laboratories. Automation has benefits such as higher efficiency and usage of less space and labor in laboratories. Thus, the market is witnessing lucrative growth as some market players are introducing automated laboratory systems and point-of-care compact, portable assay tests.

The use of antibodies in immunoassays is based on immune responses to the antigen of a particular microorganism. On the other hand, in molecular diagnostics, nucleic acid probes are based on specific genetic makeup. Thus, the adoption of molecular diagnostic tests is expected to increase over the forecast period, which may restrain the growth of the market for immunoassays.

The immunoassay product is crucial in controlling the spread of the coronavirus. In the lack of a vaccine or medication, the only efficient way to bound and limit the growth of illnesses and the potential number of casualties is to diagnose them. Rapid testing has proven to be an effective, quick, and easy molecular test for huge COVID-19 monitoring. SARS-CoV2 detection difficulties have been eased thanks to extensive research, appraisals, and authorizations of various immunoassay solutions and analyzers. Immunoassays like chemiluminescence, enzyme-linked, lateral flow-based point of treatment diagnostics, fast tests, and other techniques have seen an increase in their utilization.

The market has been affected by the market’s demanding regulatory standards for immunoassay product approval and the technical challenges of immunoassay products and reagents. Due to the widespread diagnosis of COVID-19, the immunoassay industry in various countries has seen tremendous expansion throughout the epidemic. Moreover, as the number of COVID-19 cases rises in the third wave, the market is projected to rise even more.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Disposable Surgical Devices Market – The global disposable surgical devices market size was valued at USD 5.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2021 to 2028.
  
  
• Nordic Regulatory Affairs Market – The Nordic regulatory affairs market size was valued at USD 153.2 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028.

Immunoassay Market Segmentation

Grand View Research has segmented the global immunoassay market on the basis of product, technology, application, end-use, and region:

Immunoassay Product Outlook (Revenue, USD Million, 2018 – 2030)

• Reagents & Kits
  • ELISA Reagents & Kits    
  • Rapid Test Reagents & Kits          
  • ELISPOT Reagents & Kits              
  • Western Blot Reagents & Kits    
  • Other Reagents & Kits  
• Analyzers/Instruments
  • Open Ended Systems
  • Closed Ended Systems
• Software & Services

Immunoassay Specimen Outlook (Revenue, USD Million, 2018 – 2030)

• Blood  
• Saliva    
• Urine    
• Other Specimens      

Immunoassay Technology Outlook (Revenue, USD Million, 2018 – 2030)

• Radioimmunoassay (RIA)
• Enzyme Immunoassays (EIA)Rapid Test
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
• Others

Immunoassay Application Outlook (Revenue, USD Million, 2018 – 2030)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Others

Immunoassay End-use Outlook (Revenue, USD Million, 2018 – 2030)

• Hospitals
• Blood Banks
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others

Immunoassay Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• November 2020: Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to measure neutralizing antibodies and has gained CE Marking.
• November 2018: bioMérieux acquired a majority stake in Suzhou Hybiome Biomedical Engineering Co. Ltd. This acquisition is expected to strengthen the company’s presence in the market in China.

Key Companies profiled:

Some prominent players in the global immunoassay market include

• Siemens Healthineers
• bioMérieux SA
• Abbott Laboratories
• Danaher Corporation (Beckman Coulter)
• Quidel Corporation
• Ortho Clinical Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson, and Company
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.

Order a free sample PDF of the Immunoassay Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Aesthetic Medicine Industry Overview

The global aesthetic medicine market size was valued at USD 99.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030. Manufacturers coming up with innovative aesthetic devices has led to an increased demand for aesthetic treatments in recent years. For instance, the introduction of technologically advanced products, such as non-invasive body contouring systems that use fat freezing technology, is expected to create lucrative opportunities for market growth in the coming years. According to the Aesthetic Society (U.S.), non-invasive body fat reduction was among the top 5 non-invasive procedures in the U.S. in 2020 with 140,314 procedures being carried out.

The COVID-19 pandemic had significantly affected the market for aesthetic medicine. Initially, social distancing and a sudden sharp cut in consumers’ income levels had negatively impacted the market. The market had witnessed a phase of short-term negative growth owing to factors such as a decline in product demand, limited operations, temporary closures of beauty centers, and disruption in the manufacturing and supply chain.

Gather more insights about the market drivers, restrains and growth of the Global Aesthetic Medicine market

However, remote working has increased the time spent on Zoom calls. Adults are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most popular procedures preferred. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined. Thus, the market has witnessed a spike during the past few months and it is expected to be in high demand throughout the forecast period.

The growing urge to look young and fit has increased the demand for aesthetic treatment in developing countries. Aesthetic procedures such as liposuction, nose reshaping, and Botox injections are gaining consumer interest in countries such as India and South Korea. According to the International Society of Aesthetic Plastic Surgery (ISAPS), India was ranked among the top 5 countries performing non-surgical procedures at a global level. This highlights the high growth prospects that lie ahead for aesthetic medicine manufacturers in the country.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Surgical Laser Market – The global surgical laser market size was valued at USD 4.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% from 2020 to 2027.
• Vaccine Storage & Packaging Market – The global vaccine storage and packaging market size was valued at USD 20.3 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 10.0% from 2020 to 2027.

Aesthetic Medicine Market Segmentation

Grand View Research has segmented the global aesthetic medicine market on the basis of procedure type, gender, end-User and region:

Aesthetic Medicine Procedure Outlook (Revenue, USD Million, 2018 – 2030)

• Invasive Procedures
  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Eyelid Surgery
  • Tummy Tuck
  • Others
• Non-invasive Procedures
  • Botox Injections
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Others

Aesthetic Medicine Procedure Gender Outlook (Revenue, USD Million, 2018 – 2030)

• Male
• Female

Aesthetic Medicine Procedure End-User Outlook (Revenue, USD Million, 2018 – 2030)

• Clinics, Hospitals, and Medical Spas
• Beauty Centers
• Home Care

Aesthetic Medicine Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• December 2021: Allergen Aesthetics, a part of AbbVie, acquired a medical technology company, Soliton, Inc. This acquisition will strengthen its portfolio of non-invasive body contouring treatments.

• September 2020: Allergan Aesthetics, a part of AbbVie and Skinbetter Science, announced the launch of a new educational partnership DREAM: Driving Racial Equity in Aesthetic Medicine initiative.

Key Companies profiled:

Some prominent players in the global aesthetic medicine market include:

• AbbVie
• Cynosure
• Evolus Inc.
• Revance Galderma
• Lumenis
• Solta Medical
• Syneron Candela
• Alma Laser

Order a free sample PDF of the Aesthetic Medicine Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Pacemakers Industry Overview

The global pacemakers market size was valued at USD 4.4 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 3.4% from 2022 to 2030. Rising incidences of CVDs, increasing cost of cardiac disease management, favorable government policies, and the launch of technologically advanced pacemakers such as the MRI safe pacemakers and leadless pacemakers are chiefly driving the growth in the market. The rising burden of cardiovascular diseases is one of the key factors for the growth of the market. Coronary heart disorder is one of the primary reasons for CVD deaths globally. The economic burden of these diseases is anticipated to be more than USD 1,044 billion by 2030, which highlights the great need for cardiac pacing devices.

The novel coronavirus had severely affected patients suffering from cardiovascular disease. The spread of COVID-19 had triggered a humongous economic impact on the healthcare and medical device industry. As per the American Heart Association, Circulation Journal, 2020, so far COVID-19 had affected 185 countries and more than 30,00,000 patients globally. Among patients with COVID-19, there is a high prevalence of CVD. Increasing demand to improve patient outcomes for various pacemaker implantations, with improved and minimally invasive procedures is the key factor driving the growth of the pacemaker market. Moreover, favorable reimbursement procedures, such as the Medicare system in the U.S. and NHS in the U.K. are among the key factors boosting the market.

Gather more insights about the market drivers, restrains and growth of the Global Pacemakers market

Medical device companies such as Boston Scientific Corporation and Medtronic are now offering new products that are covered under reimbursement packages, which benefit patients. Furthermore, organizations are more fixated on manufacturing high-end pacemakers catering to customized care. These innovations are enhancing accuracy, providing additional capabilities to enhance the workflow, and facilitating error reduction. For instance, in May 2020, the home monitoring system by BIOTRONIK offered a cost-effective and safe remote management of pacemaker patients at the Large Multi-Center Study. This is a significant move for routine remote follow-ups amidst COVID-19.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Personal Lubricants Market – The global personal lubricants market size was valued at USD 1.3 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.65% from 2023 to 2030.
  
  
• Artificial Corneal Implants Market – The global artificial corneal implants market size was valued at USD 67.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.

Pacemakers Market Segmentation

Grand View Research has segmented the global pacemakers market on the basis of product, type, application, end-use, and region:

Pacemakers Product Outlook (Revenue, USD Million, 2017 – 2030)

• Implantable pacemakers
  • Single Chamber
  • Dual Chamber
  • Biventricular Chamber
• External pacemakers

Pacemakers Type Outlook (Revenue, USD Million, 2017 – 2030)

• MRI Compatible Pacemakers
• Conventional Pacemakers

Pacemakers Application Outlook (Revenue, USD Million, 2017 – 2030)

• Arrhythmias
  • Atrial Fibrillation
  • Heart Block
  • Long QT Syndrome
• Congestive Heart Failure
• Others

Pacemakers End-use (Revenue, USD Million, 2017 – 2030)

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers
• Others

Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

June 2021: Medtronic launched the Micra AV, a self-contained, miniaturized pacemaker for delivering advanced pacing technology for atrioventricular (AV) block patients through a minimally invasive approach.

Key Companies profiled:

Some of the prominent players in the pacemakers market include:

• OSYPKA MEDICAL 
• Boston Scientific Corporation
• Zoll Medical Corporation, an Asahi Kasei Group Company
• Medtronic
• BIOTRONIK SE & Co. KG
• MicroPort Scientific Corporation
• MEDICO S.R.L.
• Shree Pacetronix Ltd.
• Abbott
• OSCOR Inc
• Lepu Medical Technology(Beijing)Co.,Ltd.

Order a free sample PDF of the Pacemakers Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Active Pharmaceutical Ingredients Industry Overview

The global active pharmaceutical ingredients market size was valued at USD 222.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.90% from 2023 to 2030. The growth can be attributed to the advancements in active pharmaceutical ingredient (API) manufacturing and the rising prevalence of chronic diseases, such as cardiovascular diseases and cancer. Favorable government policies for API production, along with changes in geopolitical situations, are boosting market growth. The API market is undergoing immense changes due to supply chain disruption by COVID-19. Countries such as India are being preferred over China for the export of API owing to geopolitical situations and the demand to reduce dependence on China for API products. Furthermore, governments of many countries have formulated plans and granted incentives to promote the production of API.

The COVID-19 pandemic had a positive impact on the global APIs market. The pharmaceutical industry was an epicenter in treating symptoms related to COVID-19, including high fever, cough, and cold. Due to the increased popularity of the pharma industry during the pandemic, the active pharmaceutical ingredients market also witnessed growth during the period. Following the World Health Organization’s declaration of the COVID-19 outbreak as a pandemic, a diverse group of renowned pharmaceutical and biopharmaceutical companies, as well as new startups, stepped forward to create therapies to combat the virus.

Gather more insights about the market drivers, restrains and growth of the Global Active Pharmaceutical Ingredients market

Scientists discovered a list of compounds that target COVID-19. Currently, there are approximately 155 compounds in clinical trials and 45 molecules in preclinical development to combat COVID-19. Four vaccines have been repurposed for treatment against COVID-19, including Chloroquine, Hydroxychloroquine, Lopinavir & Ritonavir, and Remdesivir. In March 2020, WHO started a worldwide trial of the four COVID-19 medicines. Increased investment and research and development in pharmaceutical products will propel the growth of the market further. However, the coronavirus outbreak has caused global business and economic disruption. It is expected to have a short-term impact on the active pharmaceutical ingredients industry in the first quarter of 2020.

The global geriatric population is rising. According to the UN, in 2018, the population aged 65 and above is anticipated to increase from 962 million in 2018 to 2.1 billion by 2050. Aging weakens the immune system and increases a patient’s susceptibility to acquiring infectious diseases. Moreover, impairment in body functions enhances the chances of getting other diseases, such as CVD and diabetes.

The requirement of high capital for the production of APIs is because the process needs extremely systematic protocols, which results in the outsourcing of various APIs. In addition, pharmaceutical companies benefit from API production outsourcing as it eradicates the need for expensive manufacturing unit installation and labor force. Thus, the need for cost savings boosts outsourcing. Strategic outsourcing by companies allows them to focus on core competencies, which results in increased productivity.

HPAPIs (highly potent active pharmaceutical ingredients) indicate a dramatic shift in how pharmaceutical companies use small molecules to offer new medicines. As a result of the change to HPAPIs, a pipeline of more effective drugs with lower doses has emerged. HPAPIs’ advantages, including the requirement for a lower therapeutic dose, capacity to bind to specific receptors, and high efficiency, can be attributed to their rising demand among producers and customers. The API market has always been dominated by small molecules. API manufacturers are adopting HPAPIs to differentiate themselves from the competition as the generic API industry becomes increasingly competitive.

In addition, APIs are used as Antibody Drug Conjugates (ADCs). ADCs are important and effective treatment modalities used in combination with biologically active drugs and monoclonal antibodies for cancer. APIs effectively target cancer cells while causing minimum exposure of drugs to healthy tissues. Thus, the development of cancer-specific APIs is expected to boost the API market growth.

Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.

• Infertility Drugs Market – The global infertility drugs market size was valued at USD 3,480.14 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030.
  
  
• Minimal Residual Disease Testing Market – The global minimal residual disease testing market size was estimated at USD 1.89 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.45% from 2023 to 2030.

Active Pharmaceutical Ingredients Market Segmentation

Grand View Research has segmented the global active pharmaceutical Ingredients market based on the type of synthesis, type of manufacturer, type, application, type of drug and region:

Active Pharmaceutical Ingredients Type of Synthesis Outlook (Revenue, USD Billion, 2018 – 2030)

• Biotech
• Synthetic

Active Pharmaceutical Ingredients Type of Manufacturer Outlook (Revenue, USD Billion, 2018 – 2030)

• Captive APIs
• Merchant APIs

Active Pharmaceutical Ingredients Type Outlook (Revenue, USD Billion, 2018 – 2030)

• Generic APIs
• Innovative APIs

Active Pharmaceutical Ingredients Type of Drug (Revenue, USD Billion, 2018 – 2030)

• Prescription Drugs
• Over-the-counter Drugs

Active Pharmaceutical Ingredients Application Outlook (Revenue, USD Billion, 2018 – 2030)

• Cardiovascular Diseases
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Active Pharmaceutical Ingredients Regional Outlook (Revenue, USD Billion, 2018 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• August 2021: Teva Pharmaceutical and MEDinCell received approval from the U.S FDA for a new drug application to treat schizophrenia. Moreover, legal issues are slowing down the establishment of new API facilities.

• 2020: Dr. Reddy’s Laboratories and Eli Lilly and Company faced problems with the U.S. FDA for their API plants. The presence of prominent players in this market space significantly diminishes the opportunities for a new entry into the market, as it is difficult to match the high capital requirements.

Key Companies profiled:

Some prominent players in the global active pharmaceutical ingredients market include:

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy’s Laboratories Ltd.

Order a free sample PDF of the Active Pharmaceutical Ingredients Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Skincare Devices Industry Overview

The global skincare devices market size was valued at USD 12.5 billion in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030. The increasing prevalence of skin cancer and other skin diseases is contributing largely to the high demand for skincare devices. Furthermore, growing awareness among people about the esthetic appeal and technological advancements in skincare devices are also increasing the adoption of these devices significantly. The rise in disposable income is also considered as one of the important factors driving the market.

The prevalence of melanoma and non-melanoma skin cancers is rising significantly. According to The Skin Cancer Foundation, around 10,130 people die due to melanoma every year in the U.S. Furthermore, American Cancer Society 2018 statistics stated that in the U.S., around 91,270 new melanoma cases are expected to be diagnosed in that year. Meanwhile, the American Academy of Dermatology (AAD) estimated that 1 in 3 Americans visit dermatologists, and 1 in every 4 are affected with skin disease every year. Hence, there is a growing need for rapid diagnosis of skin disorders.

Gather more insights about the market drivers, restrains and growth of the Global Skincare Devices market

The COVID-19 pandemic had significantly affected the market for skincare devices. Initially, the lockdown and supply chain disruption had negatively affected the market. Short-term negative growth was observed in the market due to almost entirely suspension of non-COVID-19 related surgeries, limited operations of manufacturing, and disruption in the supply chain. However, the market for dermatological devices has seen a V shape recovery. With the successful rollout of vaccines in all regions, the volume of dermatological devices is beginning to recover to its pre-pandemic levels. In 2021, the market has witnessed high demand due to the backlog of 2020 and increased interest from people related to dermatological procedures.

The market has witnessed high volatility during the past few months and is expected to return to its normal growth trend by 2023. The market for skincare devices is developing rapidly due to growing esthetic awareness. In the current scenario, people of all age groups are increasingly concerned about enhancing their esthetic appeal. Complete skin rejuvenation improves the esthetic appeal of a person. There has been a latent shift from using conventional products to technologically advanced equipment, which aids in better diagnosis and treatment of various skin diseases as well as improve one’s esthetic appeal. The introduction of technologically advanced noninvasive laser therapies has led to the high demand for skincare devices.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• Intubation Tubes Market – The global intubation tubes market size was estimated at USD 2.6 billion in 2022 and is expected to witness a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030.

• GCC And UAE Diabetes Devices Market – The GCC and UAE diabetes devices market size was valued at USD 2.76 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.

Skincare Devices Market Segmentation

Grand View Research has segmented the skincare devices market on the basis of product, application, end-use, and region:

Skincare Devices Product Outlook (Revenue, USD Million, 2018 – 2030)

• Diagnostic Devices
  • Dermatoscopes
  • Microscopes
  • Other Imaging Devices
  • Biopsy Devices
• Treatment Devices
  • Light Therapy Devices
  • Lasers
  • Electrosurgical Equipment
  • Liposuction Devices
  • Microdermabrasion Devices
  • Cryotherapy Devices

Skincare Devices  Application Outlook (Revenue, USD Million, 2018 – 2030)

• Diagnostic Devices
  • Skin Cancer Diagnosis
  • Other
• Treatment Devices
  • Hair Removal
  • Skin Rejuvenation
  • Acne, Psoriasis, and Tattoo Removal
  • Wrinkle Removal and Skin Resurfacing
  • Body Contouring and Fat Removal
  • Cellulite Reduction
  • Vascular and Pigmented Lesion Removal
  • Others

Skincare Devices End-use Outlook (Revenue, USD Million, 2018 – 2030)

• Hospitals
• Clinics
• Others

Skincare Devices Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

November 2021: Lancer Skincare the premier Beverly Hills-based international skincare brand teamed up with the tech startup ByondXR to launch The Virtual Lancer Dermatology Shop.

Key Companies profiled:

Some of the prominent players in the skincare devices market include:

• Alma Lasers GmbH
• Cynosure, Inc.
• Solta Medical, Inc.
• Cutera, Inc.
• Syneron Medical Ltd.
• Canfield Scientific, Inc.
• 3Gen
• Aesthetic Group
• Ambicare Health
• Image Derm, Inc.
• Fotona

Order a free sample PDF of the Skincare Devices Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Surgical Navigation Systems Industry Overview

The global surgical navigation systems market size was valued at USD 6.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.2% from 2022 to 2030. The rising prevalence of target disorders such as osteoarthritis, brain cancer, and ENT disorders along with the increasing geriatric population is expected to propel the growth. According to the World Health Organization (WHO), 9.6% of men and 18% of women suffer from various forms of arthritis. Osteoarthritis generally affects the geriatric population. Most osteoarthritis patients have difficulty in movement and are unable to perform daily activities.

Furthermore, the rising demand for minimally invasive surgeries is another factor responsible for escalating the adoption of these devices over the forecast period. Minimally invasive surgeries involve lesser incision wounds leading to quicker recovery time, shortened hospitals stay, and enhanced patient comfort. Moreover, these procedures are economically viable due to the shorter duration of hospital stays. The amount of blood loss during minimally invasive surgeries is lesser than the conventional open surgeries. Technological advancements in these procedures and the introduction of new products are expected to further drive the market.

Gather more insights about the market drivers, restrains and growth of the Global Surgical Navigation Systems market

An unprecedented rise in the population aged 60 years and above is anticipated to increase the demand for hip and knee replacement surgeries. This factor is expected to positively influence market growth. Furthermore, the presence of a supportive regulatory structure is also anticipated to drive the overall growth of the market and the demand for surgical navigation systems. Rising reimbursement coverage for orthopedic procedures, such as knee replacement is expected to fuel the adoption of these systems by the surgeons in near future.

Facing the outbreak of COVID-19, the medical setting across the globe has changed dramatically, offering unprecedented challenges to routine clinical practice. Owing to restrictions on elective procedures, the pandemic has significantly impacted the surgical navigation system market. As restrictions resulted in delays to a number of procedures. There was a 25–75% reduction in elective surgery in Japan. However, other factors, such as the demand for better patient outcomes will drive the uptake of novel technologies in navigation-assisted surgeries and support market growth. For instance, in February 2021, Royal Philips announced the introduction of ClarifEye Augmented Reality Surgical Navigation for minimally invasive spine procedures.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

• 3D Bioprinting Market – The global 3D bioprinting market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030.
  
  
• Pain Management Devices Market – The global pain management devices market size was valued at USD 6.40 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2022 to 2030.

Surgical Navigation Systems Market Segmentation

Grand View Research has segmented the global surgical navigation systems market based on application, technology, end use, and region:

Surgical Navigation Systems Application Outlook (Revenue, USD Million, 2017 – 2030)

• ENT
• Orthopedic
• Neurology
• Dental
• Others

Surgical Navigation Systems Technology Outlook (Revenue, USD Million, 2017 – 2030)

• Electromagnetic
• Optical
• Others

Surgical Navigation Systems End-use Outlook (Revenue, USD Million, 2017 – 2030)

• Hospitals
• Ambulatory Surgical Centers

Surgical Navigation Systems Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• November 2020: Stryker completed the acquisition of Wright Medical, in an attempt to enhance its global market position in trauma and extremities, providing significant opportunities to improve outcomes, advance innovation, and increase patient reach.
  
  
• September 2019: Johnson & Johnson’s DePuy Synthes successfully signed an agreement with JointPoint, Inc. According to this agreement, DePuy Synthes acquired the latter’s navigation software, which would allow surgeons to improve surgical outcomes in hip arthroplasties.

Key Companies profiled:

Some of the prominent players in the surgical navigation systems market include:

• B. Braun Melsungen AG
• Stryker
• Medtronic
• Corin
• Siemens Healthineers
• Smith+Nephew
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Zimmer Biomet
• KARL STORZ SE & Co. KG
• Amplitude Surgical

Order a free sample PDF of the Surgical Navigation Systems Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Ready To Drink Cocktails Industry Overview

The global ready to drink cocktails market size was valued at USD 782.8 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2030. The growing demand for flavored drinks with low alcohol content due to the rising health concerns is anticipated to drive the market over the forecast period. Premiumization of the product with flavors, taste, quality, and package design is further expected to drive the market.

The COVID-19 pandemic has had a positive impact on the market. Though the demand for them was already rising, the segment exploded after the COVID-19 pandemic hit the world. The growth of the at-home cocktail culture, increased concerns for health, convenience, and the enhanced quality and diversity of ready to drink cocktails are the factors behind the upsurge in demand.

The pandemic has caused many consumers to alter their buying habits and convert to online shopping in an effort to avoid exposure to the virus. In addition, in an effort to reach more consumers, brick-and-mortar retailers are beginning to realize the importance of developing an e-commerce strategy and are subsequently turning to online ordering and delivery platforms like Drizly (an online ordering and delivery platform) for expansion.

Gather more insights about the market drivers, restrains and growth of the Global Ready To Drink Cocktails market

Consumers in developed countries have become more health-conscious, thereby switching to low alcohol flavored drinks. They usually contain a low amount of alcohol, ranging from 4%-7% along with added flavors like lemon, cranberry, orange, and passion fruit, which eventually attracts health-conscious consumers. Therefore, low alcohol by volume (ABV) drinks have been gaining traction over the years. Gin and tequila-based products, in particular, have a high demand among consumers.

The per capita alcohol consumption in Russia, Australia, Brazil, China, and South Africa has declined significantly in recent years. Furthermore, changing lifestyle choices to improve health and the growing trend of responsible drinking are expected to boost the demand. Moreover, the availability of organic, gluten-free, and keto-friendly ready to drink cocktails is encouraging a greater number of consumers to adopt these products.

Growing consumer inclination toward ready-to-eat or ready-to-drink products owing to the busy lifestyles and hectic work schedules is driving the demand. The increasing working population, supported by the increasing number of working women, is anticipated to drive the market. Furthermore, the demand is driven by numerous consumers who prefer offering homemade drinks at house parties and social gatherings.

Browse through Grand View Research’s Alcohol & Tobacco Industry Research Reports.

• Premium Spirit Market – The global premium spirit market size to be valued at USD 235.74 billion by 2027 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% during the forecast period. The growing popularity of high-end drinks among the millennial population has been fueling market growth across the world.

• Canned Wine Market – The global canned wine market size to be valued at USD 571.8 million by 2028, expanding at a compound annual growth rate (CAGR) of 13.2% during the forecast period. The rising demand for convenient, portable, and single-serve beverages is the key driver for the market growth.

Ready To Drink Cocktails Market Segmentation

Grand View Research has segmented the global ready to drink cocktails market on the basis of type, packaging, distribution channel, and region:

Ready To Drink Cocktails Type Outlook (Revenue, USD Million, 2017 – 2030)

• Malt-based
• Spirit-based
• Wine-based

Ready To Drink Cocktails Packaging Outlook (Revenue, USD Million, 2017 – 2030)

• Bottles
• Cans

Ready To Drink Cocktails Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

• Hypermarkets/Supermarkets
• Online
• Liquor Stores

Ready To Drink Cocktails Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• January 2022: The Coca-Cola Company has signed a brand authorization agreement with Constellation Brands Inc. to launch FRESCA Mixed, a line of full-flavored, spirit-based ready-to-drink (RTD) cocktails in the U.S. 

• March 2021: Diageo plc launched a new ‘Crown Royal ready to drink cocktails’ for whisky and cocktail enthusiasts. It includes three classic, signature Crown Royal serves in flavors of apple, cranberry, cola, and peach tea.

Key Companies profiled:

Some prominent players in the global ready to drink cocktails market include: –

• Diageo plc
• Brown-Forman
• Bacardi Limited
• Asahi Group Holdings, Ltd.
• PernodRicard
• Halewood Wines & Spirits
• SHANGHAI BACCHUS LIQUOR CO., LTD.
• Suntory Holdings Limited
• Manchester Drinks Company Ltd.
• Anheuser-Busch InBev

Order a free sample PDF of the Ready To Drink Cocktails Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Vegan Cheese Industry Overview

The global vegan cheese market size was valued at USD 2.43 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.6% from 2022 to 2030. Increasing acceptance of veganism, especially among millennials, has been fueling market growth. The growing awareness regarding animal cruelty and the negative impacts on the environment caused by the dairy industry has encouraged consumers to opt for plant-based products.

The COVID-19 pandemic has offered some respite to the market as people around the world have taken an unprecedented interest in cooking at home. Hence, the demand for vegan food products has significantly increased during this period. For instance, the plant-based food trade in the U.S. reached USD 7.0 billion in 2020, increasing from USD 5.0 billion in 2019. This scenario is likely to keep the market prospects upbeat.

Gather more insights about the market drivers, restrains and growth of the Global Vegan Cheese market

Shifting consumer food preferences and evolving trends in the food and beverage industry are driving the demand for vegan cheese across the globe. The rising cases of lactose intolerance and other food-related allergies among children and adults have changed the food preferences of consumers in recent years. According to the data provided by the Food Intolerance Network, in 2019, around 70% of the population of the world suffered from lactose intolerance.

The inclination toward veganism and vegetarian diet among millennials is expected to boost the industry growth in the Hotel/Restaurant/Café (HoReCa) sector. For instance, in Saudi Arabia, vegan restaurants were established across the region for promoting a healthy lifestyle.

In addition, the growing awareness regarding animal cruelty and global concerns over carbon footprint due to the animal-based diet has encouraged consumers to opt for plant-based products. Furthermore, apart from meat, the vegan population avoids all types of animal-derived products, including cheese, milk, cream, yogurt, and even honey, which will support the market growth.

Browse through Grand View Research’s Consumer F&B Industry Research Reports.

• Salmon Fish Market – The global salmon fish market was valued at USD 14.87 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2022 to 2030. Increasing product launches in various forms including frozen, canned, and freeze-dried are likely to favor the overall market growth.

• Frozen Bakery Market – The global frozen bakery market was worth USD 42.95 billion in 2022, expected to expand at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030. The rising popularity of frozen bakery products owing to their properties such as low cost, ease of preparation, and widespread availability are major factors propelling the global market growth.

Vegan Cheese Market Segmentation

Grand View Research has segmented the global vegan cheese market on the basis of product, source, end use, and region:

Vegan Cheese Product Outlook (Revenue, USD Million, 2017 – 2030)

• Mozzarella
• Cheddar
• Parmesan
• Ricotta
• Cream Cheese
• Others

Vegan Cheese Source Outlook (Revenue, USD Million, 2017 – 2030)

• Soy
• Almond
• Cashew
• Coconut
• Others

 Vegan Cheese End-use Outlook (Revenue, USD Million, 2017 – 2030)

• B2C
• B2B

Vegan Cheese Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• July 2021: Upfield launched a vegan cheese brand Violife in the Middle East. The brand is an allergen-free, alternative range to dairy and would be available in slices, boxes, and grated in two flavors such as cheddar and mozzarella.

• March 2020: Treeline Cheese launched a line of plant-based cream cheese that is made using cultured cashew nuts and various other plant-based ingredients. It is available in three flavors including plain, chive and onion, and strawberry. 

Key Companies profiled:

Some prominent players in the global vegan cheese market include:

• Treeline Cheese
• Follow Your Heart
• Daiya Foods Inc.
• Kite Hill
• Violife
• Dr-Cow Tree Nut Cheese
• Tofutti Brands, Inc.
• Tyne Chease Limited
• Miyoko’s Creamery
• Parmela Creamery

Order a free sample PDF of the Vegan Cheese Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter